Cholesterol synthesis inhibitor has potential to be add-on therapy to statin in patients with high CV risk
3' education - Mar. 19, 2019 - Anne Carol Goldberg, MD
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!